Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 32
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
After the Readout: How the Field Is Interpreting Compass’ Phase 3 Psilocybin Data
Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts
Compass Provides Fuller Phase 3 Picture, MADRS Curves, on Webcast
BREAKING: Second Positive Phase 3 for Compass’ Psilocybin, Though Modest Magnitude Raises Questions
AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh Deal
How Do You Find the Right Facilitator? The Art of Matchmaking...
Pα+ Psychedelic Bulletin #186: As Trump Takes Office, Impact on Psychedelics...
Bifurcation Squared: Compass Lobbies for Narrow Rescheduling in Colorado, Virginia; Pushes...
Is the DEA Sabotaging Psychedelic Research? Inside the Push to Schedule...
Psychedelics in 2024: From Hype to Hard Realities
mpathic Co-Founder Danielle Schlosser on AI Oversight of Psychedelics Trials
Patent Analysis: Lykos Suffers Blow from USPTO As All Patent Claims...
Kama Flight: The Healing Power of Somatic Movement, Communication, and Trust
PsychedeliCare Launches First European Citizens’ Initiative Demanding Political Action on Psychedelic-Assisted...
Pα+ Psychedelic Bulletin #185: Joe Rogan on Ibogaine; Wisconsin Medicaid to...
Load more